Patent Assignment
Reel/Frame 074437/0826
Assignment of Assignor's Interest
Recorded: 2026-04-22
Received: 2026-04-22
Pages: 12
Assignor
BELLEROPHON THERAPEUTICS, INC. / BELLEROPHON PULSE TECHNOLOGIES LLC
Executed: 2024-06-07
Assignee
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
COLLEGE BUSINESS AND TECHNOLOGY PARK, CRUISERATH ROAD, BLANCHARDSTOWN, DUBLIN, IEX, D15 TX2V, IRELAND
Covered Property
(1)
Use of Inhaled Nitric Oxide (Ino) for Treating Patients with Pulmonary Hypertension Associated with Sarcoidosis (Ph-Sarc)
Application:
18/726,314 →